Molecular effects of curcumin on the experimental autoimmune encephalomyelitis

Laleh Mavaddatiyan1, Shiva Khezri1, Seyyed Meysam Abtahi Froushani2

  • 1Department of Biology, Faculty of Sciences, Urmia University, Urmia, Iran.

Insights

Curcumin improved experimental autoimmune encephalomyelitis (EAE) in rats by boosting myelin basic protein (MBP) gene expression and lowering NOGO-A expression. This suggests curcumin may be a potential therapeutic for EAE and multiple sclerosis (MS).

Area of Science:

  • Neuroimmunology
  • Pharmacology

Background:

  • Experimental autoimmune encephalomyelitis (EAE) serves as a model for multiple sclerosis (MS).
  • Myelin degradation in MS and EAE is linked to reduced myelin basic protein (MBP) and increased inducible nitric oxide synthase (iNOS) and NOGO-A gene expression.

Purpose of the Study:

  • To investigate the therapeutic potential of curcumin in EAE.
  • To evaluate the effect of curcumin on the gene expression of MBP, NOGO-A, and iNOS in an EAE rat model.

Main Methods:

  • EAE was induced in Wistar rats using guinea pig spinal cord homogenate and Freund's complete adjuvant.
  • Curcumin's effect on MBP, NOGO-A, and iNOS gene expression was analyzed using Reverse Transcription-Polymerase Chain Reaction (RT-PCR).

Main Results:

  • Curcumin administration increased the expression of the MBP gene in EAE rats.
  • Curcumin treatment reduced the expression of the NOGO-A gene in EAE rats.

Conclusions:

  • Curcumin demonstrates a therapeutic effect on EAE.
  • The findings suggest curcumin can modulate key gene expressions associated with EAE pathology, potentially offering a new therapeutic avenue for MS.

Related Concept Videos